PurThread, a startup focused on incorporating antimicrobials into fabrics and yarns, has formed a global partnership with Burlington to incorporate its technology.
The companies disclosed the agreement on Wednesday. Financial details were not disclosed.
“We are excited to develop progressive antimicrobial products with one of the most well-known and respected textile manufacturers in the world,” said Lisa Grimes, CEO of PurThread. “This partnership will bring to healthcare and consumer markets the powerful, durable benefits of PurThread’s protective yarns in Burlington’s high-quality fabrics. Everyone wins.”
The firms will target providing antimicrobial and anti-odor protection for healthcare, industrial, and apparel markets.
“Burlington is proud to continue its advanced R&D efforts to bring leading innovations in textile technology that provide real, lasting enhancements to our customers through our partnership with PurThread,” said Jeff Peck, president of Burlington. “Following rigorous testing, PurThread’s embedded antimicrobial is found to be extremely effective and durable, and we look forward to introducing PurThread’s benefits in our Burlington brand fabrics.”
Burlington is eyeing PurThread’s silver-embedded yarn. A recent study showed that 99.99 percent of salmonella and other bacteria were killed on a fabric surface within two hours.
PurThread says it is the first firm to embed silver into the fiber itself before it is spun into yarn and woven into fabrics. “This novel technology yields intrinsic antimicrobial benefits that don’t wash off or wear away for the life of the fabric or change the fabric’s physical characteristics,” the company says.
“We are excited to develop progressive antimicrobial products with one of the most well-known and respected textile manufacturers in the world,” said Lisa Grimes, CEO of PurThread. “This partnership will bring to healthcare and consumer markets the powerful, durable benefits of PurThread’s protective yarns in Burlington’s high-quality fabrics. Everyone wins.”
